Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs

JAMA

Volumn 276, Issue 6, 1996, Pages 466-469

  Radford, M Gene ^a   Holley, Keith E ^b   Grande, Joseph P ^b   Larson, Timothy S ^b   Wagoner, Richard D ^b   Donadio, James V ^b   McCarthy, James T ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; DICLOFENAC POTASSIUM; DIURETIC AGENT; ENALAPRIL; FENOPROFEN; FENOPROFEN CALCIUM; FUROSEMIDE; HYDROCHLOROTHIAZIDE; IBUPROFEN; KETOPROFEN; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PHENYLBUTAZONE; PREDNISONE; STEROID; SULINDAC; TOLMETIN;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG WITHDRAWAL; EDEMA; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; OSTEOARTHRITIS; PRIORITY JOURNAL; REMISSION;

EID: 9444270935     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.6.466     Document Type: Article

References (17)

1. Donadio JV Jr, Torres VE, Velosa JA, et al. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int. 1988;33: 708-715.
2. Warren GV, Korbet SM, Schwarte MM, Lewis EJ. Minimal change glomerulopathy associated with nonsteroidal antiinflammatory drugs. Am J Kidney Dis. 1989;13:127-130.
3. Porile JL, Bakris GL, Garella S. Acute interstitial nephritis with glomerulopathy due to nonsteroidal anti-inflammatory agents: a review of its clinical spectrum and effects of steroid therapy. J Clin Pharmacol. 1990;30:468-475.
4. Cahen R, Trolliet P, Francois B, Chazot C. Fenoprofen-induced membranous glomerulonephritis. Nephrol Dial Transplant. 1988;3:705-706.
5. Tattersall J, Greenwood R, Farrington K. Membranous nephropathy associated with diclofenac. Postgrad Med J. 1992;68:392-393.
6. Miatello VR, Carbajal BF, Gotlieb D, Sadler TN. Sindrome nefrotico consecutive a la ingestion de fenilbutazona. Prensa Med Argent. 1959;46:2551-2558.
7. Campistol JM, Galofre J, Botey A, Torras A, Revert L. Reversible membranous nephritis associated with diclofenac. Nephrol Dial Transplant. 1989;4:393-395.
8. Sennesael J, Van den Houte K, Verbeelen D. Reversible membranous glomerulonephritis associated with ketoprofen. Clin Nephrol. 1986;26:213-215.
9. Schillinger F, Montagnac R, Milcent T. Membranous glomerulonephritis after diclofenac treatment. Kidney Int. 1987;32:428-429. Abstract.
10. Garrouste O, Bauwens M, Touchard G, Pourrat O, Patte D. Glomérulite extra-membraneuse et néphrite interstitielle aiguë après prise de diclofénac. Ann Med Interne (Paris). 1990;141:627-628.
11. Champion de Crespigny PJ, Becker GJ, Ihle BU, Walter NM, Wright CA, Kincaid-Smith P. Renal failure and nephrotic syndrome associated with sulindac. Clin Nephrol. 1988;30:52-55.
12. Ducret F, Pointet P, Pichot C. Glomérulonéphrite extra-membraneuse: toxicité probable du dielofénac au cours d'une polyarthrite rhumatoïde. Nephrologie. 1980;1:143-144.
13. Hurault de Ligny B, Faure G, Béné MC, Kessler M, Huriet C. Glomérulonéphrite extra-membraneuse au cours du traitement d'une polyarthrite rhumatoïde par diclofénac. Nephrologie. 1984;5:135-136.
14. Hay NM, Bailey RR, Lynn KL, Robson RA. Membranous nephropathy: a 19 year prospective study in 51 patients. N Z Med J. 1992;105:489-491.
15. Figueroa JE, Waxman J. Membranous nephropathy in rheumatoid arthritis. South Med J. 1982;75:480-482.
16. Heaney DJ, Kupor LR, Gyorkey F, Weinman EJ, Schloeder FX. Membranous nephropathy associated with rheumatoid arthritis. South Med J. 1978;71:467-469.
17. Adu D, Berisa F, Howie AJ, et al. Glomerulonephritis in rheumatoid arthritis. Br J Rheumatol. 1993;32:1008-1011.